NCT01944111

Brief Summary

Compare plicated laparoscopic adjustable gastric banding to standard laparoscopic adjustable gastric banding in prospective clinical trial.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Sep 2013

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2013

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

September 12, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 17, 2013

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
Last Updated

September 17, 2013

Status Verified

September 1, 2013

Enrollment Period

1 year

First QC Date

September 12, 2013

Last Update Submit

September 16, 2013

Conditions

Keywords

Gastric plication

Outcome Measures

Primary Outcomes (1)

  • Weight loss

    Weight loss 4 weeks post surgical:20% additional than without plication, 3months post surgical: 30% additional than without plication, 6 months post surgical:30-40% additional than without plication, 1 year post surgical = 30-40% additional than without plication \& at 1 year patient will require 50% fewer adjustments than without plication.

    at least 1 year

Study Arms (1)

Plication

EXPERIMENTAL

Prospective clinical trial comparing Standard Adustable Gastric Banding versus experimental Adjustable Gastric Banding

Device: Plication

Interventions

PlicationDEVICE

Prospective clincial trial comparing adjustable gastric banding with plication versus standard adjustable gastric banding. Variables to be studied include patient age, gender, ethnicity, co-morbid disease conditions, height, weight, BMI, intra-operative data such as operative time and blood loss and post-operative outcomes including length of hosptial stay, complication rates, weight loss, and co-morbid disease resolution.

Also known as: Lap Band Plication, Adjustable gastric Banding with Plication
Plication

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age older than 18 years
  • Morbidly Obese
  • BMI \>40 or
  • BMI \>35 plus co-morbid obesity related disease conditions
  • Without contraindications to bariatric surgery: eg pregnancy, desire to become pregnant within the next 12 months, myocardial infarct within the last 6 months, cancer within last 5 years, end stage renal/liver disease
  • Without any metabolic or medically correctable causes for obesity: eg untreated hypothyroidism, Prader-Willi

You may not qualify if:

  • Patients with any major medical problems contraindicating surgery
  • Patients with a medically treatable cause of obesity
  • Patients who elect to undergo a surgery other than Plication adjustable gastric banding or standard adjustable gastric banding
  • Alcohol or drug addiction
  • Established infection anywhere in the body at the time of surgery
  • Previous history of bariatric surgery, intestinal obstruction, or adhesive peritonitis
  • Family or patient history of autoimmune disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Des Peres Hospital

St Louis, Missouri, 63122, United States

Location

MeSH Terms

Conditions

Weight Loss

Condition Hierarchy (Ancestors)

Body Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • James S Scott, MD

    Tenet Healthcare Corporation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 12, 2013

First Posted

September 17, 2013

Study Start

September 1, 2013

Primary Completion

September 1, 2014

Study Completion

September 1, 2014

Last Updated

September 17, 2013

Record last verified: 2013-09

Locations